Your session is about to expire
← Back to Search
Abelacimab for Atrial Fibrillation (LILAC-TIMI 76 Trial)
LILAC-TIMI 76 Trial Summary
This trial studies the effect of a drug on stroke or SE risk in AF patients unable to take oral anticoagulants.
LILAC-TIMI 76 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLILAC-TIMI 76 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LILAC-TIMI 76 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a mechanical heart valve or need one due to my valve disease.My atrial fibrillation is due to a temporary cause like surgery or untreated thyroid issues.I have been diagnosed with Atrial Fibrillation or flutter confirmed by an ECG.I or my doctor think blood thinners taken by mouth aren't right for me.I have not had a brain or eye bleed in the last 3 months or any brain bleed without blood thinner treatment.I am 65-74 with a high stroke risk score or 75+ with a moderate stroke risk score.I have a condition or take medication that increases my risk of bleeding.I have taken blood thinners like warfarin or dabigatran in the last 2 months.I have not had a stroke or mini-stroke shortly before joining the study.
- Group 1: Abelacimab (MAA868)
- Group 2: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Abelacimab (MAA868) obtained authorization from the FDA?
"Abelacimab (MAA868) is deemed safe, with a score of 3 given the presence of efficacy-supporting data and numerous safety trials."
What is the scope of recruitments for this experiment?
"Affirmative, the entry on clinicaltrials.gov states that this medical trial is in its active recruitment phase. Originally posted on December 27th 2022 and most recently updated January 25th 2023, this experiment requires approximately 1900 participants from 3 different sites."
Are there any slots open for volunteers within this trial?
"Affirmative. Data located on clinicaltrials.gov demonstrates that this study, first posted on December 27th 2022, is presently accepting applicants. Approximately 1900 people need to be accepted from 3 trial locations."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger